Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5643_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
374 Herbal Pharmacopeia
28. Petrovic, S., Bita, B., & Barbinta- Patrascu, M.-E. (2024). Nanoformulations in pharmaceutical and bio-
medical applications: Green perspectives. International Journal of Molecular Sciences, 25(11), 5842. https://doi.org/10.3390/ijms25115842
29. Petrovic, S. M., & Barbinta- Patrascu, M.-E. (2023). Organic and biogenic nanocarriers as bio- friendly
systems for bioactive compounds’ delivery: State- of- the- art and challenges. Materials, 16(20), 7550. https://doi.org/10.3390/ma16207550
30. Rabe, T., & van Staden, J. (1997). Antibacterial activity of South African plants used for medicinal pur-
poses. Journal of Ethnopharmacology, 56(1), 81–87. https://doi.org/10.1016/s0378-8741(96)01515-2
31. Ranzato, E., Martinotti, S., & Burlando, B. (2011). Wound healing properties of jojoba liquid wax: an in
vitro study. Journal of Ethnopharmacology, 134(2), 443–449. https://doi.org/10.1016/j.jep.2010.12.042
32. Rao, S. V., Anusha, L., Rathan, B. H., Soniya, S., & Padmalatha, K. (2023). Nanopharmaceutics: A
novel drug delivery technology. Journal of Population Therapeutics and Clinical Pharmacology, 30(3), 888–903. https://doi.org/10.15586/jptcp.v30i3.1071
33. Rotblatt, M. (2000). Herbal medicine: Expanded commission E monographs. Annals of Internal
Medicine, 133(6), 487. https://doi.org/10.7326/0003-4819-133-6-200009190-00031
34. Rupali, Sanjay Patare. (2022). Nanotechnology in herbal drug: a review. International Journal of
Scientic Development and Research. 7(12), 127–135.
35. Sahu, A.N. (2013). Nanotechnology in herbal medicines and cosmetics. International Journal of Research
in Ayurveda and Pharmacy 4(3), 472–474.
36. Sharma, M.. (2014). Applications of Nanotechnology Based Dosage Forms for Delivery of Herbal Drugs.
Research and Reviews: Journal of Pharmaceutics and Nanotechnology. 2(1), 23–30.
37. Singh, S. P., Kumar, S., Mathan, S. V., Tomar, M. S., Singh, R. K., Verma, P. K., Kumar, A., Kumar, S.,
Singh, R. P., & Acharya, A. (2020). Therapeutic application of Carica papaya leaf extract in the manage­ment of human diseases. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 28(2), 735–744. https://doi.org/10.1007/s40199-020-00348-7
38. Udupa, S. L., Shetty, S., Udupa, A. L., & Somayaji, S. N. (2006). Effect of Ocimum sanctum Linn. on
normal and dexamethasone suppressed wound healing. Indian Journal of Experimental Biology, 44(1), 49–54.
39. Vasdev, N., Pawar, B., Gupta, T., Mhatre, M., & Tekade, R. K. (2023). A bird’s eye view of various cell-
based biomimetic nanomedicines for the treatment of arthritis. Pharmaceutics, 15(5), 1150. https://doi. org/10.3390/pharmaceutics15051150
40. Verma, A., Gautam, S. P., Bansal, K. K., Prabhakar, N., & Rosenholm, J. M. (2019). Green nano-
technology: Advancement in phytoformulation research. Medicines, 6(2), 39. https://doi.org/10.3390/ medicines6020039
41. Wang, S., Chen, Y., Guo, J., & Huang, Q. (2023). Liposomes for tumor- targeted therapy: A review.
International Journal of Molecular Sciences, 24(5), 2643. https://doi.org/10.3390/ijms24052643
42. Wang, Z., Qiao, R., Tang, N., Lu, Z., Wang, H., Zhang, Z., Xue, X., Huang, Z., Zhang, S., Zhang, G.,
et al. (2017). Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance­guided focused ultrasound ablation of lung cancer. Biomaterials, 127, 25–35. https://doi.org/10.1016/j. biomaterials.2017.03.020
43. Xu, L., Choi, T. H., Kim, S., Kim, S.-H., Chang, H. W., Choe, M., Kwon, S. Y., Hur, J. A., Shin, S. C.,
Chung, J. I., Kang, D., & Zhang, D. (2013). Anthocyanins from black soybean seed coat enhance wound healing. Annals of Plastic Surgery, 71(4), 415–420. https://doi.org/10.1097/SAP.0b013e31824ca62b
44. Yadav, D., & Malviya, R. (2023). Novel nanomaterials as photo- activated cancer diagnostics and therapy.
Medicare Advantage, 1(3), 190–209. https://doi.org/10.1016/j.medadv.2023.100023
45. Yan, W., Leung, S. S., & To, K. K. (2020). Updates on the use of liposomes for active tumor targeting in
cancer therapy. Nanomedicine, 15(3), 303–318. https://doi.org/10.2217/nnm- 2019-0354
46. Zahmanova, G., Aljabali, A. A. A., Takova, K., Minkov, G., Tambuwala, M. M., Minkov, I., &
Lomonossoff, G. P. (2023). Green biologics: Harnessing the power of plants to produce pharmaceuticals. International Journal of Molecular Sciences, 24(17), 17575. https://doi.org/10.3390/ijms241717575
18
Comparative Analysis ofTraditional and Nano- Formulated Approaches in Viability, Targeted Delivery, and Patient Outcomes
J. Nithya Shree and A. Ronaldo Anuf
Department of Biotechnology, Kamaraj College of Engineering and Technology, Virudhunagar, India
Sohail Ahmad
Gomal Center of Biochemistry and Biotechnology, Gomal University, D.I. Khan, Pakistan

18.1 INTRODUCTION

Herbal medicine has long been a cornerstone of traditional healthcare systems worldwide, offering natural remedies for health conditions. The use of plant- based compounds for therapeutic purposes dates back thousands of years, reecting a deep- seated belief in the healing power of nature [1]. Despite their historical signicance and ongoing relevance, traditional herbal formulations often face signicant limitations that hinder their effectiveness. These challenges include high doses required for therapeutic efcacy, frequent administration, and issues with the delivery of active compounds to their intended sites of action. Additionally, traditional herbal medicines can have off- target effects, which may reduce their overall therapeutic benet and increase the risk of adverse outcomes [2].
One of the foremost obstacles to the effectiveness of herbal medicines is their poor bioavailabil­ity. Many herbal compounds suffer from low solubility and slow absorption rates, which can result in suboptimal levels of the active ingredients reaching the target tissues [3]. This issue is com­pounded by the rapid systemic clearance of these compounds, necessitating frequent dosing to achieve therapeutic effects. In response to these challenges, recent advancements in nanotechnology have emerged as a transformative approach to enhancing the delivery and efcacy of herbal medi­cines. Nano- formulated systems, utilizing a variety of nanocarriers such as liposomes, polymeric nanoparticles, solid lipid nanoparticles (SLNs), and nanoemulsions, have shown promise in address­ing the limitations of conventional herbal formulations [4].
Nanotechnology offers several advantages over traditional delivery methods. By encapsulating herbal bioactives in nanoscale carriers, these advanced systems can signicantly improve the stabil­ity and permeability of the active compounds [5]. This encapsulation not only protects the herbal ingredients from degradation but also facilitates their sustained and controlled release [6]. As a result, nano- formulations enhance the bioavailability of herbal medicines, allowing for more precise
375
376 Herbal Pharmacopeia
targeting of specic tissues or cells and reducing the need for frequent dosing [7]. This targeted approach not only improves the therapeutic value of herbal treatments but also minimizes potential side effects, leading to better patient outcomes [8].
The integration of nanotechnology into herbal medicine is not without its challenges. The devel­opment of nano- formulated herbal products requires rigorous research to ensure their safety and efcacy [9]. Regulatory hurdles also pose a signicant barrier, as there is a need for standardized manufacturing protocols and comprehensive safety evaluations for these novel delivery systems. Despite these challenges, the potential benets of nano- formulated herbal medicines are substantial. They offer the promise of enhanced therapeutic efcacy, reduced side effects, and improved patient compliance, making them a valuable addition to modern healthcare practices.
This chapter aims to provide a detailed comparative analysis of traditional and nano- formulated approaches in herbal medicine. It will explore how modern nano- formulations address the limita­tions of conventional methods, offering insights into their mechanisms of action, therapeutic advan­tages, and potential impact on patient outcomes. Additionally, the chapter will discuss ongoing research efforts, regulatory considerations, and safety issues associated with nano- formulations, emphasizing the need for continued investigation and validation to fully harness the potential of these advanced drug delivery systems. By bridging the gap between traditional herbal remedies and cutting- edge technology, this analysis seeks to highlight the promising future of herbal medicine in the context of contemporary therapeutic practices.

18.2 HERBAL PHYTOCONSTITUENTS FOR DISEASE MANAGEMENT

Herbal phytoconstituents, the bioactive compounds derived from plants, have gained signicant attention for their therapeutic properties in managing a variety of diseases [10]. These compounds, including alkaloids, avonoids, terpenoids, glycosides, and phenolic acids, have shown promise in treating chronic diseases like diabetes [11], cardiovascular disorders [12], cancer [13], infectious ailments [14], and neurodegenerative diseases [15].
For instance, avonoids and phenolic acids are known for their antioxidant and anti- inammatory effects [16, 17], while alkaloids and terpenoids exhibit antimicrobial and antiviral properties [18, 19]. Phytoconstituents such as curcumin and resveratrol are being studied for their potential antican­cer activities, particularly in inducing apoptosis in cancer cells [20, 21].
Despite their promising potential, one major challenge in applying herbal phytoconstituents is their low bioavailability due to poor solubility and absorption. To overcome this issue, modern tech­niques like phytosomes have been developed. Phytosomes bind water- soluble phytoconstituents to phospholipids, forming lipid- compatible molecular complexes that improve absorption and bio­availability [22].
Historically, herbal remedies have been vital sources of medicine, and, despite advances in allop­athy, plant- derived drugs remain a major part of modern and traditional medicine [23]. Over 70% of marketed medications are derived from natural or semi- synthetic plant sources, with research show­ing that phytoconstituents not only prevent but also treat various conditions, including fungal infec­tions [24]. Plants and their compounds have been extensively studied for antifungal activity, especially against Candida albicans [25] (Figure 18.1).
Herbs have also been widely used in traditional remedies for improving cognitive impairment and age- related memory loss. Medicinal plants, with their diverse active components, are emerg­ing as alternatives to synthetic drugs for cognitive disorders, including Alzheimer’s disease (AD) [26]. Nanocarrier systems have been developed to enhance the delivery of herbal treat­ments for AD, addressing challenges like low solubility and metabolism associated with natural compounds.
Herbal phytoconstituents have also played a crucial role in managing infectious diseases, particu­larly viral infections, before the advent of antibiotics. Many plant species containing antiviral mol­ecules have been identied, showing activity against viruses like rabies, HIV, and inuenza [27].
Comparative Analysis of Traditional and Nano-Formulated Approaches 377
FIGURE 18.1 Herbal Products for Inammation- Medication.
FIGURE 18.2 Diseases treated by phytochemicals.
With increasing drug resistance and the limited availability of suitable drug candidates, herbal sources provide signicant potential for developing new treatments for viral diseases.
Ongoing research continues to explore the potential of herbal phytoconstituents to develop novel, effective, and safe therapeutic agents for a wide range of diseases, addressing challenges like bio­availability and standardization to improve their clinical efcacy (Figure 18.2).
378 Herbal Pharmacopeia

18.3 BARRIERS TO HERBAL FORMULATIONS

Barriers to herbal formulations in modern healthcare systems arise from various challenges, includ­ing regulatory obstacles, standardization issues, and limited scientic validation [28]. Herbal prod­ucts are often required to meet safety and efcacy standards similar to pharmaceutical drugs, yet the complex and variable nature of their compositions makes it difcult to achieve uniformity in quality and dosage. The lack of standardized manufacturing processes and variability in raw materi­als further complicate the consistent performance of these products [28]. Additionally, insufcient clinical research and randomized trials hinder broader acceptance by healthcare professionals, cre­ating skepticism about their therapeutic efcacy [29]. Intellectual property rights, along with the commercialization of traditional knowledge, further complicate the integration of herbal formula­tions into mainstream medicine, while misconceptions and limited awareness inuence public trust [28]. Another signicant barrier is the poor bioavailability, stability, and inconsistent therapeutic outcomes of traditional herbal formulations [30]. Nanotechnology offers a promising solution to these barriers by enhancing the solubility, bioavailability, and stability of herbal bioactives [31]. Nanoformulations, such as polymeric nanoparticles, liposomes, SLNs, and nanoemulsions, improve the delivery and effectiveness of herbal medicines by protecting active compounds from degrada­tion and ensuring sustained, controlled release [22]. These advancements help overcome traditional obstacles, allowing herbal treatments to be more potent and long- lasting. However, nanotechnology also introduces new challenges, including safety concerns and high production costs, which require further research and regulation to ensure its successful integration into the eld.
Herbal formulations face numerous barriers in modern healthcare systems, despite the growing interest in their natural therapeutic potential. One of the primary challenges is the lack of standard­ization in the production and composition of herbal medicines [32]. Herbal products, composed of complex mixtures of phytochemicals, often suffer from variability in raw materials, making it dif­cult to ensure consistent quality, efcacy, and safety [33]. Unlike pharmaceutical drugs, which are subject to rigorous regulatory scrutiny, herbal medicines must meet similar safety and efcacy standards despite the difculties posed by their complex and variable nature. This leads to signi­cant regulatory hurdles and limits their acceptance in mainstream medicine. Additionally, the absence of extensive scientic validation, including clinical research and randomized trials [29], contributes to skepticism among healthcare professionals regarding the therapeutic effectiveness of herbal formulations. Intellectual property rights and commercialization issues further complicate the integration of traditional herbal knowledge into modern healthcare practices, while public per­ceptions are inuenced by misconceptions and limited awareness about the benets and risks of herbal medicines [34] (Figure 18.3).
Another major barrier is the inherent challenges in formulating effective herbal products. Traditional herbal formulations often exhibit poor bioavailability, stability, and inconsistent thera­peutic outcomes. The active phytochemicals in these formulations may not reach the target tissues
FIGURE 18.3 Barriers to herbal formulations.
Comparative Analysis of Traditional and Nano-Formulated Approaches 379
in sufcient concentrations, reducing their overall therapeutic efcacy [35]. Moreover, issues such as bulk dosing, limited absorption, and rapid systemic clearance make it necessary to administer higher doses or frequent treatments, which reduces patient compliance and overall treatment effec­tiveness. Processing difculties, such as the poor solubility and stability of plant- based compounds, further complicate the formulation of herbal medicines.
Nanotechnology has emerged as a promising solution to overcome many of these barriers. By integrating herbal bioactives into novel drug delivery systems such as nanoparticles, liposomes, and nanoemulsions, nanotechnology enhances the solubility, bioavailability, and stability of herbal med­icines [31]. These nanoformulations protect active compounds from degradation, enable sustained and controlled release, and improve the distribution of herbal constituents to target tissues. This not only enhances the therapeutic value of herbal formulations but also reduces toxicity and the fre­quency of administration, increasing patient compliance. However, while nanotechnology presents exciting opportunities, it also introduces new challenges, including safety concerns regarding the potential toxicity of nanomaterials and the high production costs associated with these advanced delivery systems.
Furthermore, the regulatory landscape for herbal nanoformulations remains complex, with a need for standardized guidelines to ensure consistency, safety, and quality across products [36]. Therefore, while nanotechnology holds the potential to revolutionize herbal medicine by addressing key barri­ers, further research, collaboration, and regulation are required to fully integrate it into clinical practice and maximize its benets.

18.4 STRATEGIES TO ENHANCE BIOAVAILABILITY

Enhancing the bioavailability of herbal formulations is crucial for maximizing their therapeutic efcacy and involves several strategic approaches. Nanotechnology- based delivery systems, such as nanoparticles, liposomes, and SLNs, are effective in improving the solubility, stability, and sustained release of herbal bioactives, thus enhancing their absorption and circulation time [37]. Micronization, or the reduction of particle size, increases the surface area of herbal constituents, promoting better dissolution and absorption [38].
Bioenhancers, such as piperine, curcumin, and quercetin, can further boost the bioavailability of herbal compounds by inhibiting metabolic enzymes and improving absorption [39]. Prodrug forma­tion, where inactive compounds are converted into active forms after metabolism, also enhances solubility and stability. Cyclodextrin complexation and phospholipid complexation improve the solubility and permeability of herbal constituents, facilitating their absorption. Self- emulsifying drug delivery systems (SEDDS) enable the formation of emulsions in the gastrointestinal tract, enhancing dissolution and absorption.
Permeation enhancers, like fatty acids and surfactants, increase the permeability of herbal compounds across biological membranes [40, 41], while enzyme inhibitors prevent premature metabolism, resulting in higher systemic concentrations. Mucoadhesive formulations, which adhere to mucosal tissues, prolong residence time, thus enhancing the bioavailability of herbal medicines [42]. These strategies collectively address the challenges of poor bioavailability in herbal formulations, leading to more effective therapeutic outcomes and improved patient com­pliance [43] (Figure 18.4).
Moreover, novel drug delivery systems, such as the Phytolipid Delivery System (Phytosome), improve the therapeutic effects of plant extracts by forming lipid- compatible complexes that enhance absorption and bioavailability [44]. Phytosomes, which involve binding herbal ingredients to phos­pholipids, have demonstrated improved pharmacokinetic and pharmacological parameters, making them benecial for treating a range of conditions.
Natural bio- enhancers, advanced formulation strategies like micronization and complexation, and the incorporation of nanotechnology in drug delivery are vital to optimizing the bioavailability of herbal medicinal products (HMPs) and integrating them into modern healthcare systems.
380 Herbal Pharmacopeia
FIGURE 18.4 Strategies to enhance bioavailability.

18.5 HERBAL FORMULATIONS – CONVENTIONAL DOSAGE FORMS

Herbal formulations have traditionally been available in various conventional dosage forms, each designed to cater to different therapeutic needs and patient preferences [45]. Powders, which are simply ground herbal substances, can be consumed directly or mixed with liquids, providing ver­satility but often facing challenges related to bioavailability and stability [7]. Capsules offer a con­venient and precise dosage by encapsulating herbal powders or extracts, effectively protecting the contents from degradation [46]. Tablets, compressed forms of herbal powders or extracts, provide stability and ease of administration but require specic excipients to ensure proper dissolution [47]. Herbal teas involve infusing herbs in hot water, a straightforward method that extracts water- soluble compounds, although it may not be suitable for all herbal constituents [48] (Figure 18.5).
Tinctures are highly concentrated alcoholic or hydroalcoholic extracts, offering a potent and long- lasting form of herbal medicine [49]. Extracts, concentrated preparations made with solvents
FIGURE 18.5 Conventional dosage forms.
Comparative Analysis of Traditional and Nano-Formulated Approaches 381
like alcohol or water, can be standardized to contain specic active ingredients and are often used in capsules or tablets. Syrups blend herbal extracts with sweeteners, making them more palatable and suitable for children [50]. Oils, including essential oils, are used for topical applications or avoring [51], while liniments and ointments incorporate herbal extracts into oily or waxy bases for localized treatment [52]. Poultices, fresh preparations applied directly to the skin, offer relief from pain and inammation [53].
Lozenges dissolve slowly in the mouth, providing gradual relief for throat and cough issues, and suppositories are designed for insertion into body cavities, releasing herbal constituents where needed [54]. Each dosage form has distinct advantages and limitations that impact its effectiveness and suitability for various therapeutic purposes. As traditional medicine gains renewed importance in modern healthcare, there is a focus on improving solubility, bioavailability, pharmacological activity, and stability while reducing toxicity and enhancing patient compliance [55]. Contemporary oral dosage forms include granules (such as effervescent and rapid- release types), tablets (like fast­dissolving and rapid- disintegrating varieties), capsules, suspensions, and syrups. Topical dosage forms have evolved to include products like toothpaste, natural hair dyes, face packs, hand washes, liniment sprays, roll- ons, gels, creams (emulsions), and shampoos. Modern traditional pharmacies, including Ayurvedic and Unani establishments, have embraced these new trends, creating innovative dosage forms that go beyond conventional practices [56]. Integrating these advancements into Unani and other traditional Indian medicine systems is crucial for aligning with global standards. The shift towards improved dosage forms in traditional medicine offers numerous advantages, such as enhanced solubility and bioavailability, reduced toxicity, improved pharmacological activity, better stability, effective drug delivery systems, and increased patient compliance, leading to better thera­peutic results. Herbal formulations, with their conventional dosage forms, have evolved to address contemporary therapeutic needs effectively [57].
Among these, tablets are favored for their convenience and customizable release proles, includ­ing immediate, sustained, or controlled release, allowing for tailored therapeutic effects [58]. Capsules, another popular form, can be lled with powdered extracts or essential oils, providing a palatable alternative to tablets and masking the taste of herbal ingredients.
Granules, such as effervescent and rapid- release types, dissolve in water for easy consumption and improved absorption. Suspensions offer a liquid option for patients who struggle with solid forms, while syrups, with their sweetened taste, cater to both children and adults seeking a more pleasant intake method. Topical forms like ointments and creams deliver herbal remedies directly to the skin, addressing localized conditions with anti- inammatory or analgesic effects [59] (Figure 18.6).
Liniments applied externally, offer relief for muscle and joint pain, and gels, with their non­greasy texture, are used for conditions like burns and rashes [60]. Additionally, herbal extracts are incorporated into everyday products such as shampoos and kinds of toothpaste, providing therapeu­tic benets for hair and oral care [61]. These varied dosage forms enhance the accessibility, efcacy, and patient acceptability of herbal medicines, ensuring their continued relevance in modern health­care. Recent advancements in drug delivery systems (NDDS) for plant actives and extracts, includ­ing polymeric nanoparticles, nanocapsules, liposomes, phytosomes, nanoemulsions, microspheres, transferases, and ethosomes, offer enhanced therapeutic outcomes compared to traditional formula­tions [62].
These novel systems provide notable advantages, such as improved solubility and bioavailability of herbal compounds, enhanced protection from toxicity, increased pharmacological activity, greater stability, and better distribution within tissues [63]. They also offer sustained release, protecting active ingredients from physical and chemical degradation. For example, liposomes, capable of encapsulating both hydrophilic and hydrophobic substances, are notable for their high biocompati­bility and ability to enhance therapeutic efcacy, particularly in cancer treatments [64]. Phytosomes, formed by binding herbal extracts to phosphatidylcholine, signicantly improve absorption and effectiveness, as evidenced by the increased bioavailability of silybin from silybin phytosome
382 Herbal Pharmacopeia
FIGURE 18.6 Steps involved in herbal drug formulation.
compared to traditional milk thistle extract. Nanoparticles, with their ability to enhance solubility and pharmacokinetics, are also crucial in overcoming limitations of traditional plant medicines [65].
The development and application of these NDDS technologies represent signicant advance­ments in herbal medicine, addressing longstanding challenges and improving therapeutic outcomes [66]. Although naturally produced plants have been integral to herbal medicine for decades, major pharmaceutical companies largely overlooked these products, often focusing on synthetic com­pounds [67]. However, natural products and their derivatives have gained signicant traction in healthcare, with approximately one- third of top- selling pharmaceuticals being derived from plants or microorganisms [68]. Their appeal lies in their therapeutic efcacy, lower side effects, and cost­effectiveness compared to synthetic drugs. Despite this, many natural products face challenges in clinical trials due to toxicity and biocompatibility issues [69].

18.6 NANOCARRIERS IN HERBAL DRUG DELIVERY

Herbal medicines have been used worldwide since ancient times, valued for their therapeutic benets and often associated with fewer adverse effects compared to modern pharmaceuticals. Recent advancements in drug delivery systems, particularly through nanotechnology, have greatly enhanced the effectiveness of herbal therapeutics by reducing toxicity and side effects while increasing bioavailability. The application of nanotechnology in herbal medicine is growing rap­idly, particularly in the realm of drug delivery. Nano herbal drug delivery systems offer immense potential to enhance the therapeutic activity of medicinal plants while addressing traditional limita­tions [70] (Figure 18.7).
Nanocarriers, such as micelles, liposomes, polymeric nanoparticles, and dendrimers, are engi­neered to carry both hydrophobic and hydrophilic drugs, optimizing delivery and minimizing side effects [71]. These systems have shown particular promise in treating severe diseases like cancer and diabetes, offering targeted delivery, sustained release, and improved stability of herbal compounds. For instance, in chemotherapy, nanocarriers can more effectively target tumors, reducing the toxicity of anticancer drugs and improving efcacy [71]. Nanotechnology’s integration with herbal medicine
Comparative Analysis of Traditional and Nano-Formulated Approaches 383
FIGURE 18.7 Types of nanocarriers.
is seen as a signicant leap forward in the eld of phytomedicine, enhancing treatments and opening new possibilities for safer, more effective therapies.
One of the key benets of nano- drug delivery systems in herbal medicine is improved bioavail­ability. Nanocarriers enhance the solubility and absorption of poorly bioavailable herbal compounds, leading to more effective therapeutic outcomes [72]. Targeted delivery is another advantage, as nano- delivery systems can be designed to specically target tissues, organs, or cells, improving the efcacy of herbal treatments while minimizing off- target effects. Additionally, encapsulating herbal compounds within nanocarriers protects them from degradation, ensuring long- term stability and efcacy [1] (Figure 18.8).
Controlled release is another major benet, allowing for sustained delivery of herbal compounds, reducing the frequency of dosing, and improving patient convenience [58]. Nanocarriers also enable the combination of multiple herbal ingredients, which can lead to synergistic effects and more com­prehensive treatments. Furthermore, nano drug delivery systems can be tailored to suit individual patient needs, making personalized medicine more achievable.
However, challenges such as regulatory considerations, long- term safety assessments, and the standardization of herbal formulations need to be addressed to ensure the widespread adoption and clinical translation of these innovations. Continued research and collaboration between scientists, herbalists, and clinicians will be essential in unlocking the full potential of nano drug delivery sys­tems in herbal medicine [73].
Nanotechnology has emerged as a promising eld in drug discovery and delivery, offering unique properties such as self- targeting due to the small size of nanoparticles, which can be directed to specic pathological areas without needing specic ligands [70]. Nanocarriers, used in drug deliv­ery, demonstrate signicant potential, particularly in chemotherapy, and are now being explored for herbal remedies. This combination is expected to enhance herbal medicines’ effectiveness in treat­ing chronic diseases and promoting health benets. Nanocarriers have shown the ability to enhance the bioavailability and therapeutic efcacy of plant- based medicines, overcoming challenges such as